FTC chief predicts ban on pay-for-delay deals will pass this year

03/19/2010 | Wall Street Journal, The

Federal Trade Commission Chairman Jon Leibowitz said he thinks a proposal to prohibit pay-for-delay deals between brand-name and generic-drug companies will pass this year even if the measure gets dropped from the health reform bill. Leibowitz said bipartisan support is building for the proposal, which would restrict patent settlements that prevent the early launch of generic medicines.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN